• Homologous Recombination Defects and PARP Inhibitor Sensitiv

  2026-05-27

  Borchert et al. (2019) demonstrate that gene expression profiling of homologous recombination repair (HRR) pathways in malignant pleural mesothelioma (MPM) identifies a BRCAness phenotype predictive of sensitivity to PARP inhibition, notably with olaparib. These findings highlight the potential for stratifying MPM patients for targeted therapies and inform future research on combination strategies with established agents like pemetrexed.

• (1S,3R)-RSL3: Deep Mechanisms and Decision Points in Ferropt

  2026-05-27

  (1S,3R)-RSL3, a potent glutathione peroxidase 4 inhibitor, is central to ferroptosis research and emerging cancer biology strategies. This article uniquely deciphers the molecular cascade, recent proteostasis insights, and nuanced protocol considerations that set it apart from previous guides.

• Ferrostatin-1 (Fer-1): Reliable Ferroptosis Assays in the La

  2026-05-26

  This article provides scenario-driven guidance for biomedical researchers tackling cell viability and ferroptosis assays, highlighting how Ferrostatin-1 (Fer-1), SKU A4371, delivers reproducible, data-backed results. Readers will gain actionable insights into protocol optimization and product selection, supported by recent literature and robust workflow comparisons.

• Polymyxin B Sulfate: Workflows for Gram-Negative Infection R

  2026-05-26

  Polymyxin B (sulfate) from APExBIO empowers infection and immunology research with robust, reproducible workflows for combating Gram-negative pathogens. This guide delivers protocol-ready insights, advanced troubleshooting, and practical translation of recent immune-microbiome findings for experimental success.

• Advancing Pain Circuit Research with nor-Binaltorphimine Dih

  2026-05-25

  Explore how nor-Binaltorphimine dihydrochloride is reshaping opioid receptor signaling research. This article integrates recent mechanistic insights into brain-to-spinal pain circuits, evidence-backed protocols, and translational strategy—delivering actionable guidance for researchers seeking to move beyond conventional opioid receptor pharmacology.

• Antipyrine in CNS Research: Mechanistic Insight to Translati

  2026-05-25

  Explore the pivotal role of Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) in advancing pain and fever research, blood-brain barrier modeling, and CNS pharmacokinetic workflows. This article synthesizes new experimental models with strategic guidance for translational researchers, highlighting APExBIO's Antipyrine as a gold-standard compound for reproducibility and data-driven insight.

• CH 223191: Applied Workflows for AhR Pathway and Dioxin Toxi

  2026-05-24

  CH 223191 stands out as a potent aryl hydrocarbon receptor antagonist for dissecting AhR-mediated signaling, dioxin toxicity, and regenerative biology workflows. Discover how to apply, optimize, and troubleshoot CH 223191 in advanced environmental toxicology and intestinal stem cell differentiation models.

• (R,S)-Anatabine: Precision Amyloid Modulation for Translatio

  2026-05-23

  This thought-leadership article explores the mechanistic intricacies and translational strategies surrounding (R,S)-Anatabine, a minor tobacco alkaloid and selective amyloid-beta pathway modulator. Drawing from recent advances in both Alzheimer's disease and skin barrier research, it provides actionable insights for researchers seeking to optimize soluble Aβ peptide reduction in vitro and in vivo. Distinct from standard product summaries, this article integrates evidence-backed protocol parameters, contextualizes (R,S)-Anatabine within the competitive neurodegeneration research landscape, and outlines how insights from adjacent domains—such as keratinocyte barrier biology—can inform the next wave of precision workflows.

• RP3-340N1.2 Knockdown Destabilizes IL-6 in NSCLC Cells

  2026-05-22

  This study identifies the lncRNA RP3-340N1.2 as a key driver of non-small cell lung cancer (NSCLC) progression via stabilization of IL-6 mRNA. Knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation through increased ZC3H12A binding, suppressing tumor cell proliferation and migration and offering a potential therapeutic angle for transcriptional regulation research.

• Puromycin Dihydrochloride: Precision Tools for Translational

  2026-05-22

  Explore how Puromycin dihydrochloride’s mechanistic versatility empowers translational researchers to move beyond routine selection and unlock new frontiers in ribosome function analysis, autophagy research, and cancer signaling studies—grounded in evidence, protocol clarity, and strategic vision.

• Applied Workflows with Losartan in Angiotensin II Signaling

  2026-05-21

  Losartan, a selective angiotensin II receptor antagonist, is a gold-standard tool for dissecting cardiovascular mechanisms and vascular cell responses. This article delivers protocol enhancements, troubleshooting strategies, and actionable integration of recent signaling insights to maximize reproducibility and discovery in hypertension and vascular biology research.

• SCH772984 HCl: Precision ERK1/2 Inhibition in Stem Cell and

  2026-05-21

  Explore how SCH772984 HCl, a potent ERK1/2 inhibitor, transforms both cancer and stem cell research. This article uniquely bridges molecular mechanism, recent telomerase regulation insights, and practical assay optimization.

• Antipyrine in Blood-Brain Barrier and Pharmacokinetic Resear

  2026-05-20

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is a gold-standard agent in blood-brain barrier modeling and pharmacokinetic studies, prized for its high solubility and reproducibility. This article delivers actionable workflows, troubleshooting strategies, and advanced insights that leverage APExBIO’s Antipyrine to accelerate CNS drug discovery.

• Antipyrine in BBB and Pharmacokinetic Workflows: Applied Ins

  2026-05-20

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is the reference standard for blood-brain barrier (BBB) permeability and drug metabolism research, now empowered by high-throughput in vitro models. Leverage APExBIO's highly pure Antipyrine for reproducible, scalable CNS drug candidate screening and get practical troubleshooting tips for optimizing your experimental outcomes.

• Vernakalant Hydrochloride: Applied Workflows in AF Conversio

  2026-05-19

  Vernakalant Hydrochloride (RSD1235) transforms atrial fibrillation research with rapid, atrial-selective ion channel blockade and clear protocol guidance. This article equips researchers with workflow enhancements, troubleshooting strategies, and data-driven insights for robust, reproducible AF conversion studies.

771 records 17/52 page Previous Next First page 上5页 1617181920 下5页 Last page